Nutex Health, Inc. (NUTX) is a Technology stock trading at $186.49 (as of 2026-08-21), with a market capitalization of $1.28B and a trailing P/E of 5.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Nutex Health operates technology-enabled healthcare services, owning and running hospital facilities (including micro-hospitals and outpatient models) and providing population health management through provider networks, and it makes money from hospital operations as well as independent dispute resolution and arbitration-related revenue and collections.
The profit engine is converting Hospital division activity into cash collected, after facility level operating costs and expenses, with additional lift tied to arbitration outcomes (including an 80% arbitration success rate and an 80% average collection rate on legal determination wins).
| Hospital | $0.2B |
| Pop Health Mgmt | $0.0B |
Business quality (Strong): High-margin operating profile in the quarter with clear operating signals (cash collected and facility cost measure), but arbitration timing and claim eligibility can make period-to-period revenue comparability harder.
Valuation: Trades at 12× trailing earnings · $1B market cap.
| Price | $186.49 |
| Market Cap | $1.28B |
| P/E Ratio | 5.5 |
| EV / EBITDA | 2.5 |
| Price / Book | 2.52 |
| Price / Sales | 1.40 |
| FCF Yield | 33.8% |
| DCF Value (model) | $924.74 |
| DCF Upside vs Price | 395.9% |
| Revenue (TTM) | $875.26M |
| Net Margin | 8.1% |
| Revenue Growth (YoY) | 82.4% |
| EPS Growth (YoY) | 8.8% |
| FCF Growth (YoY) | 1077.9% |
| Altman Z-Score | 3.58 (safe) |
| Stock P/E | 5.5 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Business Services) | 29.9 |
| vs Sector | -83.7% |
| vs Industry | -81.5% |
| Top Institutional Holder | VANGUARD GROUP INC ($42.59M) |
| Institutional Holders Tracked | 10 |
| Sector | Technology |
| Industry | Business Services |
| CEO | Thomas T. Vo |
| Employees | 800 |
| Country | US |
| IPO Date | 2022-04-04 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.